The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis.
Saved in:
| Title: | The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis. |
|---|---|
| Authors: | Tseng, Ping-Tao1,2,3 (AUTHOR) ducktseng@gmail.com, Zeng, Bing-Yan2,4 (AUTHOR), Hsu, Chih-Wei5 (AUTHOR), Hung, Chao-Ming6,7 (AUTHOR), Carvalho, Andre F.8 (AUTHOR), Stubbs, Brendon9,10 (AUTHOR), Chen, Yen-Wen3 (AUTHOR), Chen, Tien-Yu11,12 (AUTHOR), Lei, Wei-Te13,14 (AUTHOR), Chen, Jiann-Jy3,15 (AUTHOR), Su, Kuan-Pin9,16,17,18 (AUTHOR), Shiue, Yow-Ling1,2 (AUTHOR) shirley@imst.nsysu.edu.tw, Liang, Chih-Sung11,19 (AUTHOR) lcsyfw@gmail.com |
| Source: | BMC Medicine. 4/7/2025, Vol. 23 Issue 1, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-025-04018-w |
